C. Zhong

Mapping the complement-targeted landscape in igA nephropathy: a systematic review with structured descriptive synthesis

Complement inhibitors show promising but heterogeneous signals across individual trials, but marked differences in molecular targets, trial design, and eligibility preclude any inference of a uniform class effect, and underscore the need for mechanism-specific phase III programmes with hard renal endpoints and individu...